J. Kobayashi

发表

Serum lipoprotein lipase mass: clinical significance of its measurement.

H. Mabuchi, J. Kobayashi, A. Nohara, 2007, Clinica chimica acta; international journal of clinical chemistry.

Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2012, Clinica chimica acta; international journal of clinical chemistry.

J. Kobayashi, 2004, Journal of atherosclerosis and thrombosis.

High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant.

M. Yamagishi, J. Kobayashi, A. Nohara, 2017, Journal of clinical lipidology.

Isolation and characterization of the human hepatic lipase gene.

J. Kobayashi, M. Schotz, D. Ameis, 1990, The Journal of biological chemistry.

Trypsin treatment may impair the interfacial activation action of lipoprotein lipase.

Y. Morimoto, K. Shirai, J. Kobayashi, 1992, Journal of biochemistry.

Analysis of Protein Structure-Function in Vivo

N. Maeda, V. Kashyap, J. Kobayashi, 1996, The Journal of Biological Chemistry.

Replacement of Endothelial-Bound Lipolytic Enzymes in Lipase-Deficient Mice Using Recombinant Adenovirus

N. Maeda, J. Kobayashi, K. Dugi, 1996 .

Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency.

J. Sasaki, J. Kobayashi, N. Morisaki, 2000, Clinica chimica acta; international journal of clinical chemistry.

ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Clinical science.

Raloxifene promotes adipocyte differentiation of 3T3-L1 cells.

Hiroshi Sato, H. Mabuchi, J. Kobayashi, 2006, European journal of pharmacology.

Diabetes progression from "high-normal" glucose in school teachers.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Internal medicine.

Retinoid X receptor heterodimer variants and cardiovascular risk factors.

H. Mabuchi, J. Kobayashi, A. Nohara, 2009, Journal of atherosclerosis and thrombosis.

Comparison of waist circumference with body mass index for predicting abdominal adipose tissue.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Diabetes research and clinical practice.

Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population

H. Mabuchi, J. Kobayashi, K. Yagi, 2004, Endocrine.

Clinical features of a young Japanese woman having marked obesity and abrupt onset of diabetes mellitus with ketoacidosis.

J. Kobayashi, Takeyoshi Sasaki, Yasuko Ishiba, 2002, Diabetes research and clinical practice.

Management of type IIb dyslipidemia.

S. Yamashita, H. Sone, H. Arai, 2012, Journal of atherosclerosis and thrombosis.

Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells.

J. Kobayashi, W. Schneider, T. Kanaki, 2000, Biochemical and Biophysical Research Communications - BBRC.

Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Journal of atherosclerosis and thrombosis.

Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Circulation journal : official journal of the Japanese Circulation Society.

Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia.

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis: a 28-year clinical course.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Circulation journal : official journal of the Japanese Circulation Society.

Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia: A New Model for Combined Hyperlipidemia

Y. Li, B. Zhang, Huijun Sun, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2016, Lipids in Health and Disease.

Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women.

H. Mabuchi, J. Kobayashi, H. Nakagawa, 2016, Journal of epidemiology.

Lipid Management in a Japanese Community: Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017, Journal of atherosclerosis and thrombosis.

The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Atherosclerosis.

Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria.

H. Mabuchi, J. Kobayashi, M. Matoba, 2007, Circulation journal : official journal of the Japanese Circulation Society.

CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Clinical science.

Optimal Management Target for Non-High-Density Lipoprotein Cholesterol.

J. Kobayashi, H. Tada, 2016, Journal of atherosclerosis and thrombosis.

Diagnosis and management of type I and type V hyperlipoproteinemia.

S. Yamashita, H. Sone, H. Arai, 2012, Journal of atherosclerosis and thrombosis.

Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Clinica chimica acta; international journal of clinical chemistry.

The Association between Anthropometric Indices of Obesity and Chronic Kidney Disease in Middle-aged Japanese Men and Women: A Cohort Study

Y. Naruse, J. Kobayashi, H. Nakagawa, 2021, Internal medicine.

Effects of Fenofibrate Therapy on Plasma Ubiquinol‐10 and Ubiquinone‐10 Levels in Japanese Patients with Hyperlipidemia and Type 2 Diabetes Mellitus

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Pharmacotherapy.

Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

H. Mabuchi, J. Kobayashi, A. Nohara, 2007, Atherosclerosis.

Gastric Bypass in a Japanese Man with Prader-Willi Syndrome and Morbid Obesity

J. Kobayashi, S. Murano, K. Yamazaki, 2003, Obesity surgery.

Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target.

S. Yamashita, K. Shimamoto, Y. Kiyohara, 2008, Journal of atherosclerosis and thrombosis.

Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.

R. Havel, M. Malloy, J. Kane, 1991, The Journal of clinical investigation.

Significance of Kampo, Traditional Japanese Medicine, in Supportive Care of Cancer Patients

T. Sasagawa, J. Kobayashi, Y. Motoo, 2013, Evidence-based complementary and alternative medicine : eCAM.

Role of Kampo Medicine in Integrative Cancer Therapy

T. Sasagawa, J. Kobayashi, Y. Motoo, 2013, Evidence-based complementary and alternative medicine : eCAM.

Homozygous familial lipoprotein lipase deficiency without obvious coronary artery stenosis

K. Yokote, J. Kobayashi, H. Tada, 2022, Clinical Biochemistry.

A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2009, Annals of clinical biochemistry.

Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Journal of atherosclerosis and thrombosis.

Association of coronary artery ectasia with plasma insulin levels in Japanese men of heterozygous familial hypercholesterolemia with the low-density lipoprotein receptor gene mutation K790X.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, Clinica chimica acta; international journal of clinical chemistry.

Effect of walking with a pedometer on serum lipid and adiponectin levels in Japanese middle-aged men.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Journal of atherosclerosis and thrombosis.

An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma.

M. Maeda, J. Kobayashi, K. Nakajima, 2018, Clinica chimica acta; international journal of clinical chemistry.

A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase[S]

J. Kobayashi, K. Nakajima, Y. Shimomura, 2017, Journal of Lipid Research.

Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178

J. Kobayashi, K. Nakajima, 2014, Expert opinion on therapeutic patents.

A new enzyme-linked immunosorbent assay system for human hepatic triglyceride lipase.

J. Kobayashi, K. Nakajima, S. Imamura, 2013, Clinica chimica acta; international journal of clinical chemistry.

A novel method for measuring human hepatic lipase activity in postheparin plasma Published, JLR Papers in Press, November 7, 2006.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Journal of Lipid Research.

Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency -Effects of pemafibrate treatment.

J. Kobayashi, H. Tada, Takuya Minamizuka, 2020, Clinica chimica acta; international journal of clinical chemistry.

A familial hyperalphalipoproteinemia with low uptake of high density lipoproteins into peripheral lymphocytes.

T. Nishide, M. Shinomiya, K. Shirai, 1988, Atherosclerosis.

Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage.

H. Okamoto, J. Kobayashi, H. Bujo, 2002, Atherosclerosis.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.

H. Mabuchi, H. Tada, J. Kobayashi, 2014, Clinical biochemistry.

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

Lipoprotein lipase and atherosclerosis

H. Mabuchi, J. Kobayashi, 1998, Annals of clinical biochemistry.

A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama).

H. Inadera, K. Shirai, J. Kobayashi, 1993, Biochemical and biophysical research communications.

Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

H. Mabuchi, J. Kobayashi, A. Nohara, 2005, The Journal of clinical endocrinology and metabolism.

Lipoprotein lipase mass and activity in severe hypertriglyceridemia.

K. Shirai, J. Kobayashi, Y. Saito, 1993, Clinica chimica acta; international journal of clinical chemistry.

The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.

J. Kobayashi, K. Nakajima, H. Sumino, 2015, Clinica chimica acta; international journal of clinical chemistry.

The distribution of fasting and non-fasting serum triglyceride levels in Japanese population.

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Clinica chimica acta; international journal of clinical chemistry.

Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight After Washout in Japanese Men With Type 2 Diabetes

J. Kobayashi, N. Takekoshi, M. Sakurai, 2018, Journal of clinical medicine research.

Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation.

J. Kobayashi, H. Bujo, Y. Saito, 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome.

J. Sasaki, K. Yokote, J. Kobayashi, 2000, Clinica chimica acta; international journal of clinical chemistry.

The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study

M. Kakuda, J. Kobayashi, N. Takekoshi, 2017, Journal of clinical medicine research.

Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects.

M. Shinomiya, J. Kobayashi, T. Maruyama, 2001, Clinica chimica acta; international journal of clinical chemistry.

Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.

H. Mabuchi, J. Kobayashi, K. Nakajima, 2015, Journal of atherosclerosis and thrombosis.

A Clinical Feature of Diabetes Insipidus Hyperlipid emia in Patients with Central

J. Kobayashi, N. Morisaki, H. Bujo, 2006 .

A clinical feature of hyperlipidemia in patients with central diabetes insipidus.

J. Kobayashi, N. Morisaki, H. Bujo, 2000, Endocrine journal.

Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline664 to leucine mutation.

M. Shinomiya, J. Kobayashi, H. Bujo, 2000, Internal medicine.

The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins.

J. Kobayashi, K. Nakajima, S. Imamura, 2016, Clinica chimica acta; international journal of clinical chemistry.

Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium.

H. Brewer, R. Shamburek, N. Maeda, 1996, The Journal of clinical investigation.

Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population.

J. Kobayashi, S. Murano, Takeyoshi Sasaki, 2003, Diabetes research and clinical practice.

Analysis of pancreatic endocrine function in patients with IgG4-related diseases, in whom autoimmune pancreatitis was ruled out by diagnostic imaging.

M. Kawano, M. Yamagishi, J. Kobayashi, 2014, Endocrine journal.

Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, JIMD reports.

Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Effect of lipoprotein lipase on binding of chylomicrons to LDL receptor-deficient Chinese hamster ovary cells

J. Kobayashi, N. Morisaki, H. Bujo, 2001, Annals of clinical biochemistry.

Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients

M. Yamagishi, J. Kobayashi, A. Nohara, 2009, Clinical chemistry and laboratory medicine.

Reduced dimerization of lipoprotein lipase in post-heparin plasma of a patient with hyperchylomicronemia.

J. Kobayashi, H. Okuda, Y. Saito, 1995, Biochimica et biophysica acta.

Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase.

J. Kobayashi, N. Morisaki, H. Bujo, 2000, British journal of clinical pharmacology.

A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease

J. Kobayashi, 2021, Journal of atherosclerosis and thrombosis.

The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.

J. Kobayashi, K. Nakajima, Y. Ito, 2018, Clinica chimica acta; international journal of clinical chemistry.

An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum.

S. Young, M. Ploug, A. Beigneux, 2017, Journal of clinical lipidology.

An ELISA for measuring GPIHBP1 levels in human plasma or serum

S. Young, M. Ploug, J. Kobayashi, 2018 .

Significance of Kampo, Japanese Traditional Medicine, in the Treatment of Obesity: Basic and Clinical Evidence

J. Kobayashi, Y. Motoo, J. Moriya, 2013, Evidence-based complementary and alternative medicine : eCAM.

A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2011, Atherosclerosis.

Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?

J. Kobayashi, 2019, Journal of atherosclerosis and thrombosis.

Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.

J. Kobayashi, H. Bujo, Y. Saito, 2001, Clinica chimica acta; international journal of clinical chemistry.

Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2014, Atherosclerosis.

The effect of anagliptin treatment on glucose metabolism and lipid metabolism, and oxidative stress in fasting and postprandial states using a test meal in Japanese men with type 2 diabetes

M. Kakuda, J. Kobayashi, N. Takekoshi, 2015, Endocrine.

Infantile Cases of Sitosterolaemia with Novel Mutations in the ABCG5 Gene: Extreme Hypercholesterolaemia is Exacerbated by Breastfeeding.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, JIMD reports.

Effects of Long‐Term Treatment with Probucol on Serum Lipoproteins in Cases of Familial Hypercholesterolemia in the Elderly

M. Shinomiya, K. Shirai, J. Kobayashi, 1990, Journal of the American Geriatrics Society.

Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidaemia

K. Shirai, J. Kobayashi, Y. Saito, 1989, European journal of clinical investigation.

A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.

K. Shirai, J. Kobayashi, M. Schotz, 1992, Biochemical and biophysical research communications.

A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).

M. Shinomiya, K. Shirai, T. Murano, 2002, Biochimica et biophysica acta.

Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

J. Kobayashi, Xiangjing Meng, J. Moriya, 2019, Metabolites.

Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.

H. Mabuchi, J. Kobayashi, A. Nohara, 2004, Clinica chimica acta; international journal of clinical chemistry.

Comparison of the effects of losartan vs. ramipril on several adipocytokines and vascular remodeling biomarkers

H. Mabuchi, J. Kobayashi, A. Nohara, 2011, Hypertension Research.

Identification of a novel missense mutation in the sterol 27-hydroxylase gene in two Japanese patients with cerebrotendinous xanthomatosis.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2010, Internal medicine.

The Molecular Basis of the Chylomicronemia Syndrome

J. Kobayashi, M. Schotz, D. Ameis, 1991 .

Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2011, Clinica chimica acta; international journal of clinical chemistry.

Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency.

H. Mabuchi, J. Kobayashi, A. Nohara, 2008, Atherosclerosis.

Autosomal recessive hypercholesterolemia: a mild phenotype of familial hypercholesterolemia: insight from the kinetic study using stable isotope and animal studies.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2015, Journal of atherosclerosis and thrombosis.

Lipoprotein lipase mass and activity in post‐heparin plasma from subjects with intra‐abdominal visceral fat accumulation

J. Kobayashi, N. Morisaki, J. Tashiro, 1998, Clinical endocrinology.

A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.

H. Inadera, J. Kobayashi, Y. Saito, 1993, Biochemical and biophysical research communications.

Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men

J. Kobayashi, N. Takekoshi, H. Kakuda, 2013, Cholesterol.

Post‐prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, European journal of clinical investigation.

Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, Circulation. Cardiovascular genetics.

Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2016, Lipids in Health and Disease.

Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome.

M. Yamagishi, H. Mabuchi, H. Tanii, 2008, Diabetes research and clinical practice.

Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.

M. Shinomiya, J. Kobayashi, T. Maruyama, 2002, Clinica chimica acta; international journal of clinical chemistry.

Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.

H. Inadera, K. Shirai, J. Kobayashi, 1992, Metabolism: clinical and experimental.

Induction Murine Models of Chronic Fatigue Syndrome by Brucella abortus Antigen Injections: Is Anemia Induced or Not?

Y. Ishigaki, J. Kobayashi, J. Moriya, 2015, BioMed research international.

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

Ian J. Brown, Gretchen A. Stevens, Jin Su Choi, 2014, The lancet. Diabetes & endocrinology.

Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-α?

J. Kobayashi, M. Shibasaki, H. Bujo, 2002, Diabetologia.

High Frequency of a Retinoid X Receptor &ggr; Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia

Masayuki Tsuchida, Kenji Miwa, Shoji Katsuda, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Successful Treatment of Post-influenza Chronic Fatigue Syndrome with Kampo Medicine : a Case Report

J. Kobayashi, Y. Motoo, J. Moriya, 2014 .

Association of Angiopoietin-like Protein3 (angptl3) with Htgl and Lpl Activities in Human Plasma

Takeaki, H. Mabuchi, J. Kobayashi, 2022 .

Significance of a polymorphism (G-->A transition) in the -75 position of the apolipoprotein A-I gene promoter on serum high density lipoprotein-cholesterol levels in Japanese hyperlipidemic subjects.

J. Kobayashi, N. Morisaki, H. Bujo, 2001, Journal of atherosclerosis and thrombosis.

Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect

H. Mabuchi, J. Kobayashi, M. Kawashiri, 2007 .

Administration of a small amount of lard enhances intimal thickening in the balloon catheter injury model without affecting serum lipids.

M. Shinomiya, H. Inadera, K. Yokote, 1998, Scandinavian journal of clinical and laboratory investigation.

Clinical characterization of a case with familial hypobetalipoproteinemia caused by apo B-76, a new truncation of apolipoprotein B, combined with apo E2/E2 phenotype.

J. Kobayashi, H. Bujo, Y. Saito, 2001, Internal medicine.

Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan.

J. Kobayashi, N. Morisaki, H. Bujo, 2001, Atherosclerosis.

Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone

J. Kobayashi, N. Morisaki, Y. Saito, 1997, Clinical endocrinology.

Impacts of Visceral Adipose Tissue and Subcutaneous Adipose Tissue on Metabolic Risk Factors in Middle‐aged Japanese

Yoshiyu Takeda, Kunimasa Yagi, M. Yamagishi, 2010, Obesity.

Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes

H. Mabuchi, J. Kobayashi, Y. Murase, 2005, Clinical endocrinology.

A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia.

J. Kobayashi, N. Morisaki, H. Bujo, 1999, Clinica chimica acta; international journal of clinical chemistry.

Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase

J. Kobayashi, N. Morisaki, H. Bujo, 1999 .

Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus

M. Yamagishi, J. Kobayashi, A. Nohara, 2013, Journal of diabetes research.

Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.

J. Kobayashi, K. Nakajima, P. Havel, 2015, Clinica chimica acta; international journal of clinical chemistry.

Comparison of Effects of Pitavastatin and Atorvastatin on Plasma Coenzyme Q10 in Heterozygous Familial Hypercholesterolemia: Results From a Crossover Study

M. Yamagishi, H. Mabuchi, H. Tada, 2008, Clinical pharmacology and therapeutics.

The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters.

H. Mabuchi, J. Kobayashi, A. Nohara, 2006, Journal of atherosclerosis and thrombosis.

Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.

J. Kobayashi, K. Nakajima, P. Havel, 2017, Clinica chimica acta; international journal of clinical chemistry.

Lipoprotein lipase does not increase significantly in the postprandial plasma.

K. Kotani, N. Sakane, J. Kobayashi, 2017, Clinica chimica acta; international journal of clinical chemistry.

Trp64----nonsense mutation in the lipoprotein lipase gene.

M. Rymaszewski, E. Stein, I. Goldberg, 1992, Journal of lipid research.

Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2012, The American journal of cardiology.

Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma

H. Mabuchi, J. Kobayashi, K. Nakajima, 2010, Annals of clinical biochemistry.

Relationship of Lipoprotein Lipase and Hepatic Triacylglycerol Lipase Activity to Serum Adiponectin Levels in Japanese Hyperlipidemic Men

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Marked reduction in serum high-density lipoprotein cholesterol concentrations in a woman with acute inflammation due to diabetic gangrene.

J. Kobayashi, S. Murano, Akito Kudoh, 2003, Clinica chimica acta; international journal of clinical chemistry.

Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia.

J. Kobayashi, H. Bujo, Kazuo Takahashi, 2002, Atherosclerosis.

Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.

K. Shirai, J. Kobayashi, Y. Saito, 1994, Arzneimittel-Forschung.

Background to discuss guidelines for control of plasma HDL-cholesterol in Japan.

S. Yamashita, H. Sone, H. Arai, 2012, Journal of atherosclerosis and thrombosis.

Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men.

M. Yamagishi, K. Miura, J. Kobayashi, 2010, Metabolism: clinical and experimental.

Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

M. Yamagishi, H. Higashida, J. Kobayashi, 2009, Experimental diabetes research.

ResearchArticle Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

M. Yamagishi, H. Higashida, J. Kobayashi, 2008 .

Diabetic Control and Progression of Retinopathy in Elderly Patients: Five‐Year Follow‐up Study

H. Inadera, K. Yokote, J. Kobayashi, 1994, Journal of the American Geriatrics Society.

A novel method of measuring intra-abdominal fat volume using helical computed tomography

M. Shinomiya, J. Kobayashi, M. Watanabe, 2002, International Journal of Obesity.

P-214 Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009 .

Abstract 1921: Clinical Impact of Heterozygous Carrier of Autosomal Recessive Hypercholesterolemia on Asymptomatic Hyperlipidemic Patients: Evidence From Familial Gene Analysis

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2008 .

Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.

Atsuo Mori, M. Yamagishi, H. Mabuchi, 2009, Biochemical and biophysical research communications.

A new sandwich enzyme immunoassay for measurement of plasma pre-beta1-HDL levels.

T. Miida, J. Kobayashi, H. Bujo, 2000, Journal of lipid research.

Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography.

K. Hayashi, M. Yamagishi, H. Mabuchi, 2015, The American journal of cardiology.

Title Assessment of Coronary atherosclerosis in patients with familialhypercholesterolemia by coronary computed tomography angiography

K. Hayashi, M. Yamagishi, H. Mabuchi, 2017 .

methods A novel method for measuring human hepatic lipase activity in postheparin plasma

H. Mabuchi, J. Kobayashi, Akihiro Inazu, 2007 .

The relationship between post-prandial plasma glucose and post-challenge plasma glucose in Japanese population.

M. Yamagishi, H. Mabuchi, H. Tanii, 2007, Diabetes research and clinical practice.

Treatment of obesity by personality classification-oriented program.

M. Shinomiya, H. Inadera, J. Kobayashi, 1995, Obesity Research.

Severely elevated serum triglycerides in a case of heterozygous familial hypercholesterolemia with the 317 cysteine to serine mutation in the LDL receptor gene.

H. Mabuchi, J. Kobayashi, 2005, European journal of internal medicine.

Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemia.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2006, Journal of atherosclerosis and thrombosis.

Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants.

H. Mabuchi, J. Kobayashi, M. Kawashiri, 2005, Journal of atherosclerosis and thrombosis.

The relationship of abdominal fat mass assessed by helical or conventional computed tomography to serum leptin concentration.

J. Kobayashi, Takeyoshi Sasaki, M. Watanabe, 2004, Journal of atherosclerosis and thrombosis.

A naturally occurring mutation at the second base of codon asparagine 43 in the proposed N-linked glycosylation site of human lipoprotein lipase: in vivo evidence that asparagine 43 is essential for catalysis and secretion.

H. Brewer, H. Inadera, J. Kobayashi, 1994, Biochemical and biophysical research communications.

Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial.

K. Yokote, J. Kobayashi, M. Takemoto, 2021, Asia Pacific Journal of Clinical Nutrition.

Fatigue and Kampo (Japanese Herbal) Medicines: Hochuekkito and Juzentaihoto

J. Kobayashi, J. Moriya, J. Yamakawa, 2016 .

Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.

J. Kobayashi, H. Bujo, Y. Saito, 2000, Biochemical and biophysical research communications.

Difference between fasting and nonfasting triglyceridemia; the influence of waist circumference.

M. Yamagishi, K. Miura, H. Mabuchi, 2009, Journal of atherosclerosis and thrombosis.

Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2011, Atherosclerosis.

A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes.

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2009, Clinica chimica acta; international journal of clinical chemistry.

Lipoprotein lipase does not increase significantly in the postprandial plasma.

K. Kotani, N. Sakane, J. Kobayashi, 2017, Clinica chimica acta; international journal of clinical chemistry.

Association of angiopoietin-like protein3 (ANGPTL3) with HTGL and LPL activities in human plasma

Takeaki, H. Mabuchi, J. Kobayashi, 2010 .

Telmisartan Treatment Decreases Visceral Fat Accumulation and Improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients

M. Yamagishi, H. Mabuchi, J. Kobayashi, 2007, Hypertension Research.